This difference translated into different molecular effects of the two groups of variants: the cardiac LQTS variants consistently and strongly impaired calcium affinity, altered protein structure, and impaired CaV1.2 binding and regulation. The gene discussed is CACNA1C; the disease is familial long QT syndrome.